AMGN Amgen Inc. - Fundamental Analysis

NEUTRAL

AMGN Stock | Fundamental Analysis & Investment Insights

NASDAQ • Healthcare • Drug Manufacturers - General

Current Price Live

$366.21

Analyst Target

$350.03

-4.4% Downside

52W High

$391.29

52W Low

$261.43

Overview AI Snowflake Price Valuation More metrics Peers Insiders

At a glance

Key valuation, profitability, growth, and risk metrics.

Unlock key metrics

Market cap, P/E, ROE, margins, leverage and more.

AI Analysis

AI-powered fundamental assessment

Confidence

85%

Amgen Inc. (AMGN) exhibits strong deterministic health with a Piotroski F-Score of 6/9, indicating stable financials, though not in the 'strong' category. The Graham Number of $71.78 suggests deep undervaluation on a defensive basis, but the intrinsic value of $420.38 and current price of $366.21 reflect a premium justified by exceptional growth and profitability. However, the company's high debt/equity ratio of 6.40 and weak liquidity (current ratio 1.14, quick ratio 0.73) raise financial health concerns. Despite strong earnings growth and consistent beat rates, recent insider selling and a bearish technical trend temper the overall outlook.

Key Strengths

Piotroski F-Score of 6/9 indicates stable financial health with positive operating cash flow and improving profitability

Exceptional ROE of 106.10% and high gross margin (70.78%) reflect strong capital efficiency and pricing power

Consistent earnings beat history with an average surprise of 51.39% over the last four quarters

High forward P/E of 15.74 suggests market optimism on future growth despite current valuation

Strong revenue growth of 8.60% YoY and robust operating margin of 30.55% demonstrate sustainable business model

Key Risks

Debt/Equity ratio of 6.40 is extremely high, indicating significant financial leverage and potential distress risk

Insider selling activity totaling $24.82M in the last 6 months signals bearish sentiment from within the company

Technical trend score of 10/100 indicates strong bearish momentum, with price near 52-week high but showing recent weakness

Current price of $366.21 trades above the Graham Number ($71.78), suggesting overvaluation on a defensive basis

Recent Q/Q EPS growth of -10.8% contradicts strong YoY growth, indicating potential near-term deceleration

AI Fair Value Estimate

Based on comprehensive analysis

$420.38

+14.8% above current price

Performance Snowflake

Multi-dimensional AI analysis across 5 key categories

Unlock AI-Powered Analysis

See Value, Future Performance, Past Performance, Financial Health & Dividend scores

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Unlock Price Charts

View historical price trends and analyst targets

Historical Performance Trends

Long-term financial metrics and growth patterns

Unlock Historical Data

View 3-year revenue, profit margins, and growth trends

Valuation Metrics

Key valuation ratios and pricing indicators

P/E, P/B, P/S, EV/EBITDA and more

Profitability, Growth & Financial Health

Detailed profit margins, ROE, debt ratios, and liquidity metrics

Unlock Detailed Metrics

View ROE, Operating Margin, Debt/Equity, Current Ratio and more

Sector Comparison & Peer Analysis

Compare AMGN against industry averages and similar companies

Unlock Sector Insights

See how AMGN compares to competitors and industry standards

Insider Trading & Analyst Ratings

Track insider transactions and Wall Street analyst recommendations

Unlock Insider Data

See recent insider buys/sells and analyst price targets

Past News Coverage

Recent headlines mentioning AMGN from our newsroom.

Newest → oldest

Back to All Stocks

TradingGPT V1 Copilot

Fundamentals • Valuation • Risk

Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends